fda wegovy - Search News

Order byBest matchMost fresh

News

Novo Nordisk, FDA and Wegovy

· 1d · on MSN

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s blockbuster Wegovy medicine to treat a serious fatty liver disease. Shares in Novo Nordisk rose as much as 5% in early European trading Monday,

Continue reading

Fierce Pharma · 1d

Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH

BioPharma Dive · 1d

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

6m

US FDA greenlights first glucose monitoring system for weight loss

In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval ...

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

Oral Wegovy’s Pending Approval Puts Spotlight on Viability of High-Dose Peptides

While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured ...

Zacks Investment Research on MSN1d

NVO Stock Up on FDA Nod for Wegovy in MASH: More Upside Ahead?

Novo Nordisk NVO announced that the FDA has granted accelerated approval to its blockbuster GLP-1 drug, Wegovy (semaglutide 2 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results